CD36 and metabolic dysfunction-associated steatohepatitis: In addition to adipocytes, CD36 palmitoylation and the localization of CD36 on the plasma membrane of hepatocytes are significantly increased in patients with non-alcoholic steatohepatitis (NASH), as well as in livers from mice with NASH.